Home » Stocks » CYTR

CytRx Corporation (CYTR)

Stock Price: $0.7500 USD -0.0500 (-6.25%)
Updated Aug 2, 2021 3:54 PM EDT - Market closed
Market Cap 29.18M
Revenue (ttm) n/a
Net Income (ttm) -6.81M
Shares Out 36.48M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day August 2
Last Price $0.7500
Previous Close $0.8000
Change ($) -0.0500
Change (%) -6.25%
Day's Open 0.7800
Day's Range 0.7401 - 0.7800
Day's Volume 105,059
52-Week Range 0.3900 - 4.2500

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) ("CytRx" or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerati...

2 weeks ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) ("CytRx" or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerati...

3 weeks ago - Business Wire

Penny stocks to watch with upcoming event dates to keep in mind this week The post Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts appeared first on Penny Stocks to Buy, Picks, N...

Other stocks mentioned: FBIO, MBIO, MEIP, MTNB, ORPH
1 month ago - PennyStocks

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB:CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerativ...

2 months ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerati...

4 months ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerati...

Other stocks mentioned: ORPH
8 months ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerati...

9 months ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB:CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerativ...

10 months ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology and neurodegenerative diseases, today highlighted...

10 months ago - Business Wire

About CYTR

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and Aldoxorubicin, a conjugate of prescribed cytotoxin agent doxorubicin that binds to circulating albumi... [Read more...]

Industry
Biotechnology
IPO Date
Nov 10, 1986
CEO
Steven Kriegsman
Employees
4
Stock Exchange
OTCMKTS
Ticker Symbol
CYTR
Full Company Profile

Financial Performance

Financial Statements